Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland.

Jakubowska A, Narod SA, Goldgar DE, Mierzejewski M, Masojć B, Nej K, Huzarska J, Byrski T, Górski B, Lubiński J.

Cancer Epidemiol Biomarkers Prev. 2003 May;12(5):457-9.

2.

A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers.

Levy-Lahad E, Lahad A, Eisenberg S, Dagan E, Paperna T, Kasinetz L, Catane R, Kaufman B, Beller U, Renbaum P, Gershoni-Baruch R.

Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3232-6.

3.

A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.

Wang WW, Spurdle AB, Kolachana P, Bove B, Modan B, Ebbers SM, Suthers G, Tucker MA, Kaufman DJ, Doody MM, Tarone RE, Daly M, Levavi H, Pierce H, Chetrit A, Yechezkel GH, Chenevix-Trench G, Offit K, Godwin AK, Struewing JP.

Cancer Epidemiol Biomarkers Prev. 2001 Sep;10(9):955-60.

4.

The RAD51 135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers.

Jakubowska A, Gronwald J, Menkiszak J, Górski B, Huzarski T, Byrski T, Edler L, Lubiñski J, Scott RJ, Hamann U.

Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):270-5.

5.

The 3' untranslated region C > T polymorphism of prohibitin is a breast cancer risk modifier in Polish women carrying a BRCA1 mutation.

Jakubowska A, Gronwald J, Górski B, Huzarski T, Byrski T, Benner A, Lubiński J, Scott RJ, Hamann U.

Breast Cancer Res Treat. 2007 Jul;104(1):67-74. Epub 2006 Sep 27.

PMID:
17004108
6.

A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers.

Kadouri L, Kote-Jarai Z, Hubert A, Durocher F, Abeliovich D, Glaser B, Hamburger T, Eeles RA, Peretz T.

Br J Cancer. 2004 May 17;90(10):2002-5.

7.

RAD51 135G>C polymorphism and risk of familial breast cancer in a South American population.

Jara L, Acevedo ML, Blanco R, Castro VG, Bravo T, Gómez F, Waugh E, Peralta O, Cabrera E, Reyes JM, Ampuero S, González-Hormazábal P.

Cancer Genet Cytogenet. 2007 Oct 1;178(1):65-9.

PMID:
17889711
8.

Analysis of RAD51 polymorphism and BRCA1 mutations in Polish women with breast cancer.

Romanowicz-Makowska H, Smolarz B, Zadrozny M, Kulig A.

Exp Oncol. 2006 Jun;28(2):156-9.

PMID:
16837909
9.

The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers.

Kotsopoulos J, Ghadirian P, El-Sohemy A, Lynch HT, Snyder C, Daly M, Domchek S, Randall S, Karlan B, Zhang P, Zhang S, Sun P, Narod SA.

Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):912-6.

10.

Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

Kotsopoulos J, Olopado OI, Ghadirian P, Lubinski J, Lynch HT, Isaacs C, Weber B, Kim-Sing C, Ainsworth P, Foulkes WD, Eisen A, Sun P, Narod SA.

Breast Cancer Res. 2005;7(5):R833-43. Epub 2005 Aug 19.

11.

Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.

Lose F, Duffy DL, Kay GF, Kedda MA, Spurdle AB; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer; Australian Ovarian Cancer Study Management Group.

J Natl Cancer Inst. 2008 Nov 5;100(21):1519-29. doi: 10.1093/jnci/djn345. Epub 2008 Oct 28.

PMID:
18957670
12.

BRCA1 mutations and prostate cancer in Poland.

Cybulski C, Górski B, Gronwald J, Huzarski T, Byrski T, Debniak T, Jakubowska A, Wokołorczyk D, Gliniewicz B, Sikorski A, Stawicka M, Godlewski D, Kwias Z, Antczak A, Krajka K, Lauer W, Sosnowski M, Sikorska-Radek P, Bar K, Klijer R, Romuald Z, Małkiewicz B, Borkowski A, Borkowski T, Szwiec M, Posmyk M, Narod SA, Lubiński J.

Eur J Cancer Prev. 2008 Feb;17(1):62-6.

PMID:
18090912
13.

Variation in the RAD51 gene and familial breast cancer.

Lose F, Lovelock P, Chenevix-Trench G, Mann GJ, Pupo GM, Spurdle AB; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer.

Breast Cancer Res. 2006;8(3):R26. Epub 2006 Jun 8.

14.

The presence of hereditary BRCA1 gene mutations in women with familial breast or ovarian cancer and the frequency of occurrence of these tumours in their relatives.

Skasko E, Paszko Z, Niwińska A, Kwiatkowska E, Kruczek A, Pieńkowski T.

Eur J Gynaecol Oncol. 2004;25(4):470-4.

PMID:
15285306
15.

RAD51 135G>C polymorphism and breast cancer risk: a meta-analysis.

Zhou GW, Hu J, Peng XD, Li Q.

Breast Cancer Res Treat. 2011 Jan;125(2):529-35. doi: 10.1007/s10549-010-1031-8. Epub 2010 Jul 11.

PMID:
20623332
16.

Dinucleotide repeat polymorphisms of RAD51, BRCA1, BRCA2 gene regions in breast cancer.

Nowacka-Zawisza M, Brys M, Romanowicz-Makowska H, Kulig A, Krajewska WM.

Pathol Int. 2008 May;58(5):275-81. doi: 10.1111/j.1440-1827.2008.02223.x.

PMID:
18429825
17.

Interaction between genetic variations in DNA repair genes and plasma folate on breast cancer risk.

Han J, Hankinson SE, Zhang SM, De Vivo I, Hunter DJ.

Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):520-4.

18.

Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

Jernström H, Lubinski J, Lynch HT, Ghadirian P, Neuhausen S, Isaacs C, Weber BL, Horsman D, Rosen B, Foulkes WD, Friedman E, Gershoni-Baruch R, Ainsworth P, Daly M, Garber J, Olsson H, Sun P, Narod SA.

J Natl Cancer Inst. 2004 Jul 21;96(14):1094-8.

PMID:
15265971
19.

Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

Kotsopoulos J, Lubinski J, Lynch HT, Klijn J, Ghadirian P, Neuhausen SL, Kim-Sing C, Foulkes WD, Moller P, Isaacs C, Domchek S, Randall S, Offit K, Tung N, Ainsworth P, Gershoni-Baruch R, Eisen A, Daly M, Karlan B, Saal HM, Couch F, Pasini B, Wagner T, Friedman E, Rennert G, Eng C, Weitzel J, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group, Garber J, Osborne M, Fishman D, McLennan J, McKinnon W, Merajver S, Olsson H, Provencher D, Pasche B, Evans G, Meschino WS, Lemire E, Chudley A, Rayson D, Bellati C.

Breast Cancer Res Treat. 2007 Oct;105(2):221-8. Epub 2007 Jan 24.

PMID:
17245541
20.

A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.

Shu XO, Cai Q, Gao YT, Wen W, Jin F, Zheng W.

Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1462-7.

Supplemental Content

Support Center